Categories AlphaGraphs, Earnings, Health Care
Eli Lilly and Company (LLY) Earnings: 4Q22 Key Numbers
Eli Lilly and Company (NYSE: LLY) reported fourth quarter 2022 earnings results today.
Revenue fell 9% year-over-year to $7.3 billion.
Reported net income grew 12% to $1.93 billion, or $2.14 per share, compared to last year. Adjusted EPS dropped 4% to $2.09.
For FY2023, the company expects revenue of $30.3-30.8 billion and adjusted EPS of $8.35-8.55.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
TC BioPharm develops safer, less expensive products to target more cancers: CEO Bryan Kobel
TC BioPharm (NASDAQ: TCBP) is a clinical-stage cell therapy company focused on the development of treatments for infectious diseases, including advanced allogeneic chimeric antigen receptor (CAR) T-cell therapy products for
Cintas Corp. (CTAS) Q3 2023 earnings and revenue increase
Uniform rental company Cintas Corporation (NASDAQ: CTAS) on Wednesday announced financial results for the third quarter of 2023, reporting higher earnings and revenues. At $2.19 billion, third-quarter revenues were up
Infographic: Micron (MU) reports net loss for Q2; revenue down 53%
Micron Technology Inc. (NASDAQ: MU) slipped to a loss in the second quarter of 2023 from a profit last year, hurt by a sharp fall in revenues. The chipmaker reported